Suppr超能文献

结肠炎相关结直肠癌的发病机制与治疗:来自中医的见解

Pathogenesis and treatment of colitis-associated colorectal cancer: Insights from Traditional Chinese Medicine.

作者信息

Jin Yutong, Liu Haizhao, Wang Yuhui, Zhang Ruixuan, Wang Qiaochu, Wang Yao, Cui Huantian, Wang Xiangling, Bian Yuhong

机构信息

School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.

Department of Integrated Traditional Chinese and Western Medicine, Tianjin First Central Hospital, Nankai University, Tianjin, 300192, China.

出版信息

J Ethnopharmacol. 2025 Feb 10;338(Pt 2):119096. doi: 10.1016/j.jep.2024.119096. Epub 2024 Nov 10.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Inflammatory Bowel Disease (IBD) is an inflammatory intestinal disease, and with prolonged illness duration, the annual risk of IBD progressing to colitis-associated colorectal cancer (CAC) gradually increases. In recent years, there has been a noticeable trend towards the application of traditional Chinese medicine (TCM) in the treatment of CAC.

AIM OF THIS REVIEW

This comprehensive review summarizes the pathogenesis of CAC and details the therapeutic benefits of TCM in treating CAC, including various TCM prescriptions and ingredients, establishing the theoretical foundation for the application of TCM in CAC treatment.

METHODS

We assessed literature published before March 24, 2024, from several databases, including Web of Science, PubMed, Scopus and Google Scholar. The keywords used include "traditional Chinese medicine", "traditional Chinese medicine prescriptions", "traditional Chinese medicine ingredients", "herbal medicine", "colitis-associated colorectal cancer", "inflammatory bowel disease", "colorectal cancer" and "colitis-cancer transformation". We conducted a comprehensive collection and collation of pertinent scientific articles from various databases, focusing on the efficacy of TCM in the prevention and treatment of "colitis-cancer transformation".

RESULTS

This paper provides a concise summary and thorough analysis of twenty-eight prescriptions and ingredients of TCM for the prevention and treatment of CAC, based on existing experimental and clinical research. There are positive signs that TCM can effectively prevent and treat the "colitis-cancer transformation" through repairing the intestinal mucosal barrier, correcting intestinal flora imbalance, and regulating intestinal immune responses.

CONCLUSION

TCM possesses comprehensive regulatory advantages that are multifaceted, multilevel, and multitarget. It has a definite curative effect in the prevention and treatment of CAC. It is essential to enhance the clinical efficacy of TCM in the prevention and treatment of CAC based on syndrome differentiation and treatment, with the assistance of modern medicine.

摘要

民族药理学相关性

炎症性肠病(IBD)是一种肠道炎症性疾病,随着病程延长,IBD进展为结肠炎相关结直肠癌(CAC)的年风险逐渐增加。近年来,中药(TCM)在CAC治疗中的应用有明显趋势。

本综述的目的

本全面综述总结了CAC的发病机制,并详细阐述了中药在治疗CAC方面的治疗益处,包括各种中药方剂和成分,为中药在CAC治疗中的应用奠定理论基础。

方法

我们评估了2024年3月24日前发表于多个数据库的文献,包括Web of Science、PubMed、Scopus和谷歌学术。使用的关键词包括“中药”、“中药方剂”、“中药成分”、“草药”、“结肠炎相关结直肠癌”、“炎症性肠病”、“结直肠癌”和“结肠炎-癌转化”。我们对来自各种数据库的相关科学文章进行了全面收集和整理,重点关注中药在预防和治疗“结肠炎-癌转化”方面的疗效。

结果

基于现有实验和临床研究,本文对28种预防和治疗CAC的中药方剂和成分进行了简要总结和深入分析。有积极迹象表明,中药可通过修复肠道黏膜屏障、纠正肠道菌群失衡和调节肠道免疫反应有效预防和治疗“结肠炎-癌转化”。

结论

中药具有多方面、多层次、多靶点的综合调节优势。其在CAC的预防和治疗中具有确切疗效。基于辨证论治,借助现代医学提高中药在CAC预防和治疗中的临床疗效至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验